Marinella Ermacora appointed to the Institute’s Board of Directors

Sept. 6 2017 | Appointment

All news

The Montreal Clinical Research Institute (IRCM) announces the appointment of Marinella Ermacora as a new member of its Board of Directors. Ms. Ermacora is President of The Createch Group, a Bell Canada company, and has been a member of the Board of Directors of the IRCM Foundation.

Pierre Duplessis, Chairman of the Board, and Tarik Möröy, IRCM President and Scientific Director, highlighted Marinella Ermacora's outstanding commitment to the IRCM and its Foundation: “We are delighted to welcome Ms. Ermacora as a member of the Board,” they said. “As a member of the IRCM Foundation Board of Directors for the last seven years, her knowledge of the Institute's needs will be a definite asset. She also chairs the Organizing Committee of the IRCM's 50th Anniversary, which we are celebrating throughout 2017.”

Marinella Ermacora holds a Master’s degree in Business Administration, including an international exchange program from McGill University and HEC School of Management in Paris. She also holds a Bachelor’s degree in Information Management with honours from Concordia University. She is a certified administrator (ICD.D) from the Institute of Corporate Directors (McGill-Rotman).

She worked at CGI Group from 1998 until September 2010, where she took on several executive tasks. She then served as Senior Vice President, Business Solutions, at Fujitsu Canada Inc. Mrs. Ermacora is also involved in the community. She is a Board member of Convivia and a member of the Corporation du Collège de Montréal’s human resources committee.